Global Insulin Market to witness remarkable growth by 2022 :Top keyplayers are Novo Nordisk, Sanofi-Aventis, Merck & Co, Pfizer, Eli Lilly and Biocon constituting

Description

The Global Insulin Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. According to WHO, in 2015, an estimated 1.6 million deaths were directly caused by diabetes. WHO also projects that diabetes will be the seventh leading cause of death in 2030.The global insulin market encompasses both insulin drugs and delivery devices markets.

Insulin is a peptide hormone secreted by beta cells of the pancreatic islets and is considered to be the main anabolic hormone of the human body. It allows the cells of the body to use glucose for energy. When there is excess glucose in the bloodstream, insulin increases the storage of glucose as glycogen and fat. Insulin is administered externally to patients suffering from diabetes, which is the medical condition when the body is unable to maintain its blood glucose level.

Request For Free Sample@ https://www.kennethresearch.com/sample-request-10064985

Market Dynamics

The rapid growth of the insulin market is fuelled by increasing prevalence of diabetes, the rise in geriatric population, an increase in obesity, propagation of diabetes management awareness and government impetus. The generally unhealthy lifestyle of the present generation has added another dimension to the complex issue.

However, parallel factors like high cost of insulin, rising cost of insurance coverage, high competition and stringent regulations are restraining the growth of the market.
New and innovative insulin products, their commoditization and increased demand in untapped emerging economies are opportunities for the several key players in the market.

Market Segmentation

The market is segmented on various parameters. The first segment for insulin drugs is based on the mode of action into rapid-acting, intermediate-acting, long-acting and premixed insulin derivatives. This categorization is based on how fast insulin starts to work and for how long its effect lasts.

Another market segment is based on the type of insulin used - human insulin and analogue insulin. Human insulin describes synthetic insulin which is laboratory grown to mimic the insulin in humans. Analogue insulin is a genetically altered form of human insulin. Since it has a more uniform action, it is slowly replacing human insulin as the preferred form of insulin.

The market for insulin delivery devices is segmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injections. Each has its own USP - Insulin syringes are user-friendly and self-administrable, pens are compact in size and reusable, pumps are easily wearable by patients and jet injections are needleless. However, the market leader in terms of revenue is insulin pumps.

Regional/Geographic Analysis

In terms of geography, the global insulin market is segmented into North America, Europe, Asia-Pacific and LAMEA (Latin America, Middle East & Africa). The market is dominated by North America due to the high prevalence of diabetes and technological advances in efficient insulin delivery while Asia-Pacific has the fastest growing market for human insulin.

Buy Now@ https://www.kennethresearch.com/report-purchase-id-10064985

Key Players

Some of the major players in the market include Novo Nordisk, Sanofi-Aventis, Merck & Co, Pfizer, Eli Lilly and Biocon constituting the top 6 in the Global Insulin market.

The report contains comprehensive analysis on:

Global Insulin Market Segments
Global Insulin Market Drivers, Restraints and Opportunities
Global Insulin Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Global Insulin Market Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Global Insulin Market includes
North America
US and Canada
Latin America
Mexico, Brazil, Argentina and Rest of Latin America
Western Europe
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Eastern Europe
Russia
Poland
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
South Africa
North Africa
Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Read More@ https://www.kennethresearch.com/report-details/global-insulin-market/10064985

Report Highlights:

Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
Consumer and Pricing Analysis
Market dynamics of the industry
In-depth Market Segmentation
Historical and Projected Market Sizing in terms of volume and value
Recent market trends and Impact Factors
R&D Status and Technology Overview
Extensive Industry Structure Coverage

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

1412 Broadway,
21st Floor Suite MA111,
New York, NY 10018

Name:David
Email:sales@kennethresearch.com
Phone: +1 313 462 0609

This release was published on openPR.